000			02050 a2200553 4500
005			20250513130021.0
264		0	_c19971119
008			199711s 0 0 eng d
022			_a1058-4838
024	7		_a10.1086/514545 _2doi
040			_aNLM _beng _cNLM
100	1		_aWhite, A C
245	0	0	_aEffects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. _h[electronic resource]
260			_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cAug 1997
300			_a230-9 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAcinetobacter _xdrug effects
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAnti-Bacterial Agents _xadministration & dosage
650	0	4	_aBacteremia _xdiagnosis
650	0	4	_aCommunicable Disease Control
650	0	4	_aCommunity-Acquired Infections _xdrug therapy
650	0	4	_aCross Infection _xdrug therapy
650	0	4	_aDrug Resistance, Microbial
650	0	4	_aEnterobacter cloacae _xdrug effects
650	0	4	_aEscherichia coli _xdrug effects
650	0	4	_aFemale
650	0	4	_aGram-Negative Bacteria _xdrug effects
650	0	4	_aGram-Negative Bacterial Infections _xdrug therapy
650	0	4	_aHospitals, Urban _xeconomics
650	0	4	_aHumans
650	0	4	_aIntensive Care Units
650	0	4	_aKlebsiella pneumoniae _xdrug effects
650	0	4	_aMale
650	0	4	_aMedication Systems, Hospital _xeconomics
650	0	4	_aMiddle Aged
650	0	4	_aOutpatients
650	0	4	_aPseudomonas aeruginosa _xdrug effects
650	0	4	_aRisk Factors
650	0	4	_aTreatment Outcome
700	1		_aAtmar, R L
700	1		_aWilson, J
700	1		_aCate, T R
700	1		_aStager, C E
700	1		_aGreenberg, S B
773	0		_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 25 _gno. 2 _gp. 230-9
856	4	0	_uhttps://doi.org/10.1086/514545 _zAvailable from publisher's website
999			_c9305078 _d9305078